The pharmaceutical industry’s demand for high-purity intermediates is a constant driver for quality and precision in chemical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD., a premier pharmaceutical intermediate supplier in China, addresses this need with compounds like (3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azetidinone (CAS: 149198-47-0). This intermediate is critically important for the synthesis of Cabazitaxel, an effective drug used in the treatment of advanced prostate cancer.

NINGBO INNO PHARMCHEM CO.,LTD. places a strong emphasis on quality assurance, ensuring that (3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azetidinone is produced with an assay of ≥98.0%. This high purity is vital because any impurities or variations in stereochemistry could compromise the final drug's efficacy and safety profile. The compound's molecular formula is C20H31NO4Si, and its molecular weight is 377.550, reflecting its complex structure.

As a reliable pharmaceutical intermediate manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. understands the rigorous demands of the pharmaceutical sector. The compound's properties, described as a colorless to light yellow oily liquid, are managed through careful production and storage protocols. When companies seek to buy (3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azetidinone, they are looking for consistency, reliability, and adherence to international quality standards. NINGBO INNO PHARMCHEM CO.,LTD. strives to meet these expectations through its advanced manufacturing processes and robust quality control systems.

The strategic sourcing of critical intermediates like (3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azetidinone is fundamental to the uninterrupted production of essential medicines. NINGBO INNO PHARMCHEM CO.,LTD.'s dedication to quality and its position as a leading supplier in China make it an invaluable partner for pharmaceutical companies worldwide, supporting the continuous effort to develop and deliver life-saving cancer treatments.